Bill > HF2275

This bill modifies the registration fee requirements for insulin manufacturers in Minnesota by adjusting how manufacturers can be exempted from the annual $100,000 registration fee. Currently, manufacturers must pay an annual fee of $100,000, but can request an exemption if their total wholesale acquisition cost from insulin dispensing claims within Minnesota is less than five percent of the total wholesale acquisition cost of all insulin dispensing claims in the state during the previous calendar year. The bill also requires the commissioner of health to provide technical assistance to the board by using available data sources, including data collected under section 62U.04. The key changes include replacing references to "gross revenue" with "wholesale acquisition cost" and clarifying the method for calculating the exemption threshold. The bill aims to ensure a more precise and data-driven approach to assessing registration fees for insulin manufacturers, potentially making the fee structure more equitable and transparent.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=House&f=HF2275&ssn=0&y=2025